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Introduction
For decades, generations of students have been taught that 
autoimmune diseases were caused by environmental factors acting on a 
background of variable genetic susceptibility. Numerous susceptibility 
genes with the potential to influence immune function have been 
identified [1,2], but with the exception of certain drug induced 
syndromes [3] and gluten sensitive enteropathy [4] evidence about the 
actual environmental triggers has been lacking and students fobbed 
off with vague references to infectious agents; viruses and bacteria [3]. 
Although there is still dearth of evidence about the precise triggers 
of most autoimmune disease the past few decades have witnessed a 
considerable expansion in our knowledge of environmental cofactors 
that appear able to alter the immune system and skew it towards 
autoimmunity or allergy [5].
This expansion in knowledge has accompanied a significant increase 
in incidence of many autoimmune diseases over several decades since 
about the 1970s, clearly too rapidly to reflect any change in the genetic 
make-up of the various populations studied. The increase has been 
documented both in organ specific, for example type 1 diabetes [6] 
and systemic diseases including antineutrophil antibody associated 
systemic vasculitis(AASV) [7]. The increase in incidence has begged 
the question of what environmental factors may have changed leading 
to this. This review will examine this in the context of AASV. 
Wegener’s granulomatosis (now renamed granulomatous 
polyangiitis – GPA)), microscopic polyangiitis (MPA), the Churg-
Strauss syndrome (now renamed eosinophilic granulomatous 
polyangiitis –EGPA) make up the anti-neutrophil cytoplasmic 
antibody (ANCA) associated systemic vasculitides – AASV [8]. Clear 
definitions have really only been available since the development of the 
classification criteria by the American College of Rheumatology (ACR) 
in 1990 [9] and the Chapel Hill Consensus Conference (CHCC) in 1994 
[10]. The AASV are characterised by necrotising small-vessel vasculitis 
with a paucity of immune deposits, seen in renal and other biopsies in 
association with autoantibodies to cytoplasmic proteins in neutrophils. 
The predominant specificity of ANCA are proteinase 3(PR3) and 
myeloperoxidase (MPO) [11]. Interestingly, although most clinicians 
would now use ANCA to help arrive at a diagnosis, these criteria do not 
include ANCA and there is probably need for further refinement of the 
definitions used for research and clinical purposes [8,12]. 
Generally, these are diseases of the middle aged and elderly and 
are particularly rare in children suggesting that environmental factors 
may predominate over genetic factors. The gender balance of disease 
incidence is close to unity, quite unlike most systemic autoimmune 
diseases such as SLE suggesting again the importance of environmental 
factors. However there are major ethnic differences in the occurrence 
of different types of AASV and several different examples of major 
differences between White Caucasians and other ethnic groups living 
in the same location in the occurrence of all forms of AASV putting 
genetics firmly back in the frame [13-15].
Methods
The literature has been systematically searched for epidemiological, 
case control, ecological studies together with specific questions 
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Abstract
This review seeks to critically examine the environmental factors reported to be associated with anti-neutrophil 
antibody associated systemic vasculitis. The published literature was searched in a systematic fashion. From 
this emerges strong evidence for a latitude gradient in the case of granulomatous polyangiitis and eosinophilic 
granulomatous polyangiitis; both appear more common at high latitudes. Microscopic polyangiitis does not 
demonstrate this. Latitude affects ultraviolet radiation exposure and the relationship of increased incidence of 
granulomatous polyangiitis and eosinophilic polyangiitis with decreased ultraviolet radiation exposure is much 
stronger. The most plausible explanation is vitamin D levels, a hormone known to be vital for normal immune function 
and largely synthesised in humans secondary to ultraviolet radiation exposure. Case control studies demonstrate 
a consistent relationship to silica exposure a substance well known to have profound immunological effects. The 
genetic risk factors for these diseases will be considered and a model of how genes and environment may interact to 
produce these diseases discussed. Low vitamin D levels, silica exposure, other environmental triggers may interact 
with genes that influence the immune and inflammatory response to initiate and sustain these diseases. As such, 
the broad concepts developed about the etiopathogenesis of the anti-neutrophil antibody associated vasculitides 
shows many parallels to other autoimmune diseases. Much more information is required about both genes and the 
environment, but the model helps define the questions that need to be answered.
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about prominent modern risk factors; smoking, obesity, industrial 
pollutants, sedentary lifestyle and potential infectious causes. PubMed 
will be the primary search engine (last accessed September 20 2013) 
with the terms “ANCA associated vasculitis, each of the specific 
syndromes, “primary systemic vasculitis”,” vasculitis” intersecting with 
“epidemiology”, “ecological study”, ‘case control study”,” smoking”,” 
obesity”, “sedentary lifestyle”, “metabolic syndrome”, ‘vitamin 
D”, “genetics”. The proceedings of the last three (14th, 15th and 16th) 
international vasculitis and ANCA workshops and the Asia Pacific 
meeting of Vasculitis and ANCA workshop, 2012 have been examined 
for any early relevant reports that may not yet appear in PubMed. The 
gleaned information has been summarised and the way in which the 
reported environmental factors may influence the immune system has 
been discussed in the context of what is known about the pathogenesis 
of the AASV, including genetic factors to allow a discussion of possible 
mechanisms.
Results
Epidemiological studies
The published studies, both incidence and prevalence to 2011 
have been summarised previously [7,16]. A more recent study from 
Northern Germany will be included [17]. These reports have largely 
used a combination of ACR or CHCC definitions as indicated and 
most have involved multiple strategies to ensure accurate capture of 
subjects in a particular defined geographic area. Studies that precede 
the use of these definitions have been excluded. Studies from both the 
East and West of Asia (Japan and Kuwait) report little or no AASV 
other than MPA [18,19]. In the case of Japan this appears to be a 
repeatable conclusion [20]. The nature of case ascertainment in Kuwait 
may have worked against finding GPA or EGPA without renal disease 
[19]. Particular attention has been paid to reports of incidence data 
as prevalence may be affected by improved management and survival 
[21]. The findings that can be extracted from these studies can be 
considered under a number of headings. 
Age, gender and ethnicity: Overall these studies show that the 
AASV occur with advancing years with GPA peaking in the middle 
aged to elderly with a variable but small ratio of males to females(range 
M:F 1.9-0.5). In this regard, the AASV clearly differ from the 
female dominated systemic autoimmune diseases – systemic lupus 
erythematosus, Sjogren’s syndrome and scleroderma and probably 
differ in important aspects of their pathogenesis [22]. 
The AASV, in particular GPA are diseases of Caucasians of 
European origin. This is seen and remarked upon in Europe, the United 
States of America (USA) and New Zealand (NZ) [13-15]. Specifically in 
France where there were a substantial number of non-Europeans in the 
Departments of Greater Paris the overall occurrence of vasculitis was 
half that seen in the Europeans in the same geographic area [13]. In New 
York State, African Americans and Hispanics were under-represented 
in GPA when compared to the population as a whole [14]. In North 
Carolina African Americans were very under-represented compared to 
the general population [23]. Similarly, in NZ the rate of GPA amongst 
Europeans was twice that of the NZ Maoris or Asians [15]. 
Changes over time: There is evidence suggesting an increase in 
incidence of AASV over the last several decades. This is particularly 
evident in data from Scandinavia and Northern Germany. In the three 
northernmost counties of Norway the annual incidence and prevalence 
of WG rose from 5.2/million (1984-1988) to 6.5/million (1989-1993) 
to 12.0/million (1994-1998) [24]. A similar sort of increase was seen 
in Sweden [25]. In Germany there appears to be an upward trend with 
the incidence rates and years as follows: 1998, 11/million; 1999, 9.5/
million; 2000, 12/million; 2001, 12/million; 2002, 16/million [26]. A 
more recent report from the same group and population has confirmed 
a doubling in AASV from 1994 until 2006 [17]. In Norfolk, UK a lesser 
rise occurred with AASV as a whole and seems to have plateaued [27]. In 
South Eastern Australia, the incidence of AASV rose from 13.4/million 
in 1995-1999 to 15.6/million in 2000-2004 [28]. Some of this increase 
may have followed the introduction of widespread ANCA testing and 
a reclassification of idiopathic crescentic glomerulonephritis to MPA, 
although a number of authorities believe there is more to it than this. 
Analysis of the trends in more recent years shows that the increase 
continues, arguing against enhanced diagnosis as a factor [17].
Fluctuations over time: As well as a probable increase over time 
some studies have peaks and troughs in the disease occurrence, every 
4-5 years a peak of WG in Norway [24], similarly every 3-5 years in 
central Sweden [29] and every 3 years for AASV as a whole in Spain 
[30]. The group from Norfolk have recently reported a seven year 
periodicity for WG, but none for MPA [31]. Temporal clustering 
however has been sought and not found in other studies [32-34]. 
There are yet no explanations such as infectious disease cycles or UVR 
fluctuations reported to explain these findings.
The season of onset: The season of onset has been examined 
in a number of these studies with conflicting results. A winter peak 
is evident in data from Norfolk and Sweden [29,35]. This pattern is 
supported by hospital based data from other sources [26,33,34], 
although in one study it was really a spring/winter peak [36]. A study 
from the USA reported an increase in autumn and spring [14], from NZ 
an increase in autumn and decrease in spring [37] and a recent French 
survey has paradoxically shown a summer peak [38]. This prompted a 
re-examination of the Norfolk data which now shows a non-significant 
winter peak, a summer trough and no relation to the serial changes in 
a number of important upper respiratory tract pathogens [39]. While 
different factors may contribute to the pathogenesis in different places 
providing a plausible explanation for these quite different results a 
number of other studies do not support seasonality at all [24,25]. 
Indeed, given that patients with AASV will experience a prodromal 
stage to their illness of quite variable length it is not surprising that 
such conflicting results are evident and at this stage, no conclusions 
about etiology can be drawn.
Latitudinal gradient: A latitudinal gradient exists, perhaps 
shown most elegantly for GPA in Caucasians of European origin 
NZ where the method of case ascertainment is identical for the 
whole country [22,37]. A less clear cut gradient is also evident in the 
northern hemisphere, perhaps because of minor variations in case 
ascertainment, or ethnic differences [16,40]. The latitudinal differences 
in the northern hemisphere also relate to the relative frequencies of 
the different subsets of AASV with GPA predominating in Norway 
and MPA predominating in Spain and even more so in Japan and 
Kuwait [18,19]. While ethnic variation may contribute to the latter, the 
differences between northern and southern Europe are unlikely to be 
major. Taken with the NZ data make it much more likely that there are 
environmental factors causing this.
Urban-rural differences: Some studies suggest that GPA is more 
common in rural areas although most do not have or do not present 
data to address this issue and no consistent pattern emerges [16,41]. 
In the Australian Capital Territory and surrounding region there is 
such a difference, which is interesting as the two major risk factors in 
our view, UVR, and silica exposure would be in conflict in terms of 
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the hypothesis presented below and perhaps the balance elsewhere is 
different.
Ecological study
A subset of these published epidemiological studies where incident 
data, total population of the study region and age-specific incidence 
rates and study location was provided has been taken and an ecological 
study seeking any relationship with measures of ambient Ultra-Violet 
radiation (UVR) carried out. In contrast to latitude, which changes 
in a linear manner towards both poles ambient UVR decreases in a 
geometric fashion as one moves towards the poles, even more so in 
winter. Ambient UVR was obtained from satellite data using the 
longitude and latitude of the largest urban centre in any given area. 
Both the ambient UVR level weighted to erythemally effective 
wavelengths (UVery) and to vitamin D effective wavelengths (UVvitD) 
under both blue sky and cloudy conditions was estimated. Winter UVR 
as well as mean daily ambient UVR was recorded because there is a 
stronger latitudinal gradient in winter UVR compared with summer 
UVR and a known limitation on vitamin D production from available 
winter UVR at high latitudes. It is noteworthy in our analysis that the 
data from Kuwait was excluded as the methods of ascertaining cases or 
the precise denominator population from which the study was drawn 
was not clear from this publication. The crude incidence rates of both 
EGPA and GPA increased with latitude, although only GPA achieved 
statistical significance. Using a negative binomial regression there was 
a modest increase in the incidence of both EGPA (3.4%) and GPA 
(3.5%) per a higher degree of latitude. MPA showed no association 
in either analysis, although it is possible that our exclusion of the 
data from Kuwait prevented demonstration of a previous negative 
correlation with latitude [18]. As was predicted the relationships were 
much stronger with ambient UV radiation with a stronger inverse 
correlation demonstrable for GPA than EGPA. As expected there was 
no relationship between any measure of UVR and MPA [21].
Although UVR has local effects on the immune system in the skin 
[41] and as such is of particular importance in SLE, the most plausible 
explanation for these findings is through the effects on vitamin 
D synthesis, a hormone that has profound effects on the immune 
system which has been reviewed in a wide range of inflammatory 
rheumatological conditions [42]. There is however no population data 
on vitamin D from the populations for which we have AASV incident 
data and no series measuring vitamin D in patients and matched 
controls.
Case control studies
Nine case control studies have been summarised in previous 
publications [16,40]. They vary in quality; some had quite small numbers 
and were probably underpowered. Nevertheless taken together they 
allow a few conclusions. The dominant risk fact is silica, both crystalline 
silica and silica found in crop dusts. Silica has a major impact on the 
immune system, is associated with a number of autoimmune syndromes 
and is most the immune system, is associated with a number of 
autoimmune syndromes and is most commonly inhaled, so the results 
are not so surprising [43]. The association is seen in AASV where there 
is no respiratory tract disease, suggesting that the impact of silica goes 
beyond the immediately exposed airways. These findings are supported 
by other reports of silica associated AASV, including Japanese study 
from Kobe showing an increased occurrence and severity of AASV for 
three years after the devastating 1995 earthquake when compared to the 
unaffected neighbouring Kyoto prefecture. The authors attribute this to 
dust and other particulate air pollution, the dust contained silica [44]. 
Silica of course is often not inhaled alone and this needs to be borne in 
mind. The most interesting conclusion from the Kobe earthquake is 
that the environmental impact can be quite proximate in a temporal 
sense that is the effect came and went soon after the original challenge 
[44]. Heavy metal exposure comes up in some in some studies, as do 
solvents and pesticides [16,40]. Farming appeared an at risk occupation 
in a minority of studies; farmers are exposed to silica contained in dust. 
As has been discussed above when urban and rural differences have 
been examined the results are conflicting. Allergy and drug allergy (in 
general) appear in two of the studies [16,40]. Atopy is common, allergy 
may be over-reported and some of the clinical features, for example, 
sinusitis may be seen as part of the clinical spectrum of vasculitis itself. 
Unfortunately, case control reports do not include any data about 
personal UVR exposure or vitamin D levels.
Infection
 Not surprisingly, there has been from the outset a suspicion that 
infection may trigger episodes of AASV. Infection could be involved 
in the primary etiology of AASV; infection could trigger episodes 
of relapse or both [45]. The role of Staphyloccus aureus in triggering 
relapses and the possible mechanisms of action has been explored. 
Their work demonstrates increase nasal carriage of staphylococci and 
a correlation between nasal carriage and relapse [46]. Specific types 
of Staphylococcus appear to be present during relapse [47]. However, 
the role of nasal carriage has been explored in parallel with EUVAS 
trials with a much less clearcut picture emerging, although the number 
of swabs taken was far less (D Jayne, unpublished observations). A 
suggestion that staphylococcal toxic-shock-syndrome-toxin may play 
a part in GPA [48] is not supported by the nature of the disease where 
the time frame and pathology are quite unlike that seen in an accepted 
superantigen induced disease such as the toxic shock syndrome or 
probable superantigen induced disease such as the vasculitis Kawasaki 
syndrome [49]. More recently an initially exciting finding provided 
evidence for molecular mimicry between the human LAMP-2 epitope 
(a common ANCA specificity) and bacterial adhesion FimH derived 
from many gram negative organisms [50]. This quite compelling 
hypothesis remains in limbo as the serological studies have proved 
difficult to repeat in other laboratories [51].
An observation that a patient who received TMP-SX for a urinary 
tract infection with Escherichia coli had an apparent coincident 
improvement in their intercurrent GPA lead to TMP-SX being used for 
induction therapy in GPA, a situation where except perhaps for limited 
nasal disease its efficacy is suspect and for maintenance therapy, where 
it appears to have an adjunctive role [52]. While this may represent an 
antimicrobial effect, there is no proof of that and TMP-SX may also 
have intrinsic immunosuppressive properties [53].
Cigarette smoking
Cigarette smoke contains multiple active compounds that can 
potentially interact with the immune system. Any effects could be 
local in the airways or systemic. All three AASV have prominent 
respiratory tract features. The data however are less compelling. A small 
retrospective study showed fewer smokers in patients with AASV than 
a matched control population [54]. An analysis of patients enrolled in 
4 EUVAS sponsored controlled trials and repeated in the Vasculitis 
Quality of Life study indicated that smokers were more likely to have 
vasculitis related gastro-intestinal disease than non-smokers [55]. This 
effect of smoking parallels that observed in Crohn’s inflammatory 
bowel disease but what the observation means in terms of the overall 
etiopathogenesis of AASV is unclear. 
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Drugs and toxic chemicals
The above case control series suggest in some cases a general 
association with drug allergy without being specific. There are more 
specific associations including propylthiouracil(PTU) which can 
trigger both ANCA AASV [56]. Some patients have recovered 
completely on cessation of the PTU, others have required conventional 
immunosuppressive therapy [56,57]. Hydralazine has been similarly, 
but less frequently reported [58]. The ANCA seen with drug induced 
disease appear much more heterogeneous with additional specificities 
such as lactoferrin, cathepsin G and azurocidin and a long list of less 
frequent neutrophil antigens [59].
The role of certain classes of medication in precipitating EGPA 
has been of particular concern. Thus a number of post-marketing 
surveillance reports have appeared linking EGPA to the use of 
leukotriene receptor antagonists (LTRA), including both cysteinyl 
leukotriene receptor blockers – montelukast, zafirlukast and pranlukast 
and zileuton, a 5 lipoxygenase inhibitor [60]. Some patients may have 
been prescribed these drugs for severe asthma which was already on 
the path EGPA, but probably not all [60]. Macrolide antibiotics have 
been associated with EGPA in a series of case reports [61-63]. In most 
cases, it is hard to distinguish between the use of a macrolide to treat 
a putative respiratory tract infection in a patient already developing 
EGPA and a true association, although in one case there was a positive 
challenge [63]. Not only is the data in regard to at least some drugs 
still open to question, but no overall hypothesis pointing to a disease 
mechanism emerges from these studies. Similarly, although it is 
popular to blame environmental exposure to all sorts of chemicals or 
xenobiotics for the occurrence of autoimmunity little emerges from the 
case control studies and much more work is needed [64].
Obesity and the metabolic syndrome
An increased body mass index, particularly if accompanied by 
the metabolic syndrome has demonstrable effects on the immune 
system [65]. Obesity and the metabolic syndrome seem to have a close 
association with disturbances of the normal gastrointestinal flora 
[66]. Many health problems are thought to arise from perturbations 
and in the context of inflammatory syndromes, including potentially 
many autoimmune diseases obesity and the metabolic syndrome are 
associated with active innate and acquired immune systems [67]. 
Studies specific to AASV are so far limited but an increased incidence 
of metabolic syndrome has been reported in AASV. A follow-up report 
of outcome is awaited. 
Sedentary lifestyle
Regular exercise appears to be anti-inflammatory [68] but there are 
no studies to date in AASV demonstrating either benefit of exercise or 
specific detriment of a lack of exercise. Such relationships have been 
demonstrated in type 1 diabetes [69].
Genetics of AASV
Ethnic differences described above including between White 
Caucasians in France, the USA and NZ and people of Arab descent, 
African Americans and Polynesians and Asians respectively suggest 
that genetics may be important [13-15]. Genetic studies in AASV 
include a number of case control studies exploring plausible risk genes 
and a recent genome wide association study (GWAS) [70]. All three 
syndromes are rare in children, occurring in the middle aged to elderly 
suggesting that genetic effects are not particularly strong. Familial 
clustering, unlike many other autoimmune syndromes appears to 
be quite rare [71]. Most susceptibility genes in autoimmune diseases 
encode a phenotype that interacts with the immune system; some 
susceptibility genes affect the putative autoantigens. In considering 
susceptibility genes consideration will be given as to their possible 
mode of action, after all such pathophysiological studies will give us the 
complete picture hinted at by genetic findings. 
Known genetic associations include genes that encode proteins 
known to be important in T cell activation. All of these genetic 
associations are quite weak with odds ratios of 2-3 generally. There 
are some MHC class II linkages; DP1*0401 with GPA and MPA in 
Caucasians and DRB1*0901 with MPA in Japanese and DRB4 with 
EGPA [72-75]. An allelic form of CTLA-4, a negative regulator of T cell 
activation encodes a less efficient protein which would be associated 
with persistent immune activity [73]. In contrast the gene (T1858) 
encoding the lymphoid tyrosine phosphatise (PTPN-22) encodes an 
allelic variant Lyp*W620, increased in GPA and MPA, which is a less 
effective regulator of T cell activity, unless one speculates that this 
factor is more active in regulatory T cells its actions seem at odds with 
expectations. There remains some contention about the mechanism of 
this protein in human cells [76]. There is also an association of variants 
of CD226 that would increase integrin-mediated activation of naive 
cells [73]. 
There is also an association with genes and their products involved 
in inflammation. GPA is associated with the dysfunctional alpha-1 
antitrypsin alleles, Z and S [77]. The association with increased copy 
number of FCRG3B is however disputed in GPA, but reported in 
EGPA [72,78]. 
The GWAS confirmed the association in white Europeans of HLA 
DBP1*0401, the SERPINA1 locus which encodes alpha-1-antitrypsin 
and added the PRTN 3 locus which encodes PR3. The relationships 
are strongest with PR3-ANCA positive subjects. A weaker association 
between MPO positive subjects and HLA-DQ was noted. The study 
was not powered to examine details. It is noteworthy in the study that 
all associations were stronger with the antibody profile, anti-PR3 and 
MPO [70].
Discussion
The discussion will be focussed on drawing these factors into current 
plausible models for these 3 diseases bearing in mind that despite 
their similarities there almost certainly are distinct etiopathogenetic 
pathways in the different syndromes [79]. The principal aim of the 
discussion is to ensure that any models of disease pathogenesis takes 
account of the relevant environmental and genetic factors discovered to 
date and described here. The one fact that is certain in regard to putative 
etiologic factors is that our current knowledge is incomplete and as 
such concepts about etiopathogenesis must be somewhat speculative. 
To ground these consideration will be given to the better publicised 
current models [11,79,80]. These models do tend to be overarching 
and endeavour to account for all forms of AASV, or at least GPA and 
MPA whereas both the genetic and environmental differences suggest 
that there may be common and different pathways. Class 2 MHC genes 
are associated with all three forms of AASV although the risk alleles 
are distinctly different for each and not yet identified in every ethnic 
group studied. Overall this is consistent with the idea that antigen 
under MHC control is being presented to CD4 T cells. The different 
MHC relationships suggest that the antigens may be different. This is 
in accord with current understanding, PR3 and MPO being important 
antigens in GPA and MPA respectively. EGPA provides a problem in 
that a significant number of cases are MPO-ANCA negative. Those with 
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glomerulonephritis that show more clinical overlap with other AASV 
tend to be MPO-ANCA positive [81]. Based upon the environmental 
and genetic findings described so far, animal models and ex vivo 
studies in AASV a model that accounts for the current known facts 
has been proposed by a number of groups [11,79,80]. A number of 
assumptions appear to have been made in these reviews, which can be 
challenged. Firstly, although the evidence from both animal models 
and passive transplacental acquisition of transient MPA that anti-
MPO ANCA play a role in the pathogenesis of MPA is quite strong 
neither convincing animal models nor a human experiment of nature 
have been documented for anti-PR3 [11]. A role of the diagnostic or 
marker antibodies in actual disease pathogenesis cannot be assumed 
and given that renal biopsies are largely pauci-immune the role of CD4 
Tcells, particularly in PR3 associated disease may be as effectors, not 
just as potential controllers of auto-antibody synthesis. The recurrence 
of both GPA and MPA after B cell and ANCA depletion with rituximab 
without the return of ANCA also argues against an indispensable role 
of ANCA [82]. The findings about PR3 in the GWAS provide further 
support for the importance of this protein as an autoantigen [70]. The 
additional genetic factors so far identified would most likely play a role 
in modifying the autoimmune response as it develops. Encoded allelic 
differences in those discovered so far, CTLA-4 and PTPN-22 would 
operate at a T cell level. The allele encoded in the case of CTLA-4 in 
fact does act to make negative regulation less efficient and could be 
expected to be associated with exuberant immune reactivity [73]. 
The PTPN-22 allelic variant increased in both GPA and MPA would 
at first sight appear to operate in the converse direction and creates a 
problem with the hypothesis unless it is more active in regulatory T 
cells. This gene is however very interesting when seeking explanations 
for the major ethnic differences. This allele is quite common in White 
Caucasians and quite rare in other ethnic groups. Does that contribute 
to the restricted occurrence of GPA in this ethnic group? Further work 
will be needed to answer this question. Once a T cell driven response 
occurs neutrophils feature prominently in GPA and MPA and genes 
that would enhance neutrophil activity such as those encoding 
dysfunctional alpha-1-antitrypsin would be expected to play a role 
here. The genetic influences are each on their own relatively weak, 
but appear to act to up-regulate lymphocyte activity and the concept 
of quantitative thresholds for immune-cell signalling has allowed an 
understanding of how multiple genetic factors of a relatively small 
effect may combine to create a state of susceptibility to autoimmunity [2].
The environmental observations show both overlap between 
syndromes but also clear and profound differences and the current 
proposed models include a degree of homogeneity in regard to 
the pathogenesis of the three syndromes that is not justified by 
the literature quoted in support and indeed quite different, albeit 
overlapping mechanisms may be expected [11,80]. At this time the 
dilemma is most readily resolved by separating out the pathogenesis 
of granulomas, seen in GPA and EGPA from necrotising vasculitis 
involving small arteries, arterioles, capillaries and venules, common 
to all three syndromes [11,79,80]. Current evidence suggests that the 
vasculitic lesions involve neutrophil activation, possibly abetted by 
ANCA and consequent neutrophil enzyme and other product mediated 
vascular damage [11,80]. As TH17 cells predominate in the capacity to 
recruit neutrophils, these T cells are probably involved and if antibody 
production is really integral to the development of vasculitis then TH2 
cells are presumably involved [11]. Granulomas are generally regarded 
as a product of disturbed innate and cellular immunity and in the 
context of GPA and potentially EGPA with overactive Th1 and TH17 
cells and a reduction in numbers and/or activity of Treg cells [83,84]. 
The known environmental factors can be reconciled with this model. 
The impact of low vitamin D, in turn secondary to low UVR would be 
manifest through increased TH1 and Th17 and decreased Tregs and 
associated with granuloma formation, consistent with the latitudinal 
gradient seen with both GPA and EGPA, but not MPA where there 
are no granulomas [85]. Silica exposure has been associated with 
decreased Tregs and increased Th17 [43] and has been shown to bind 
to the neutrophil peptide LL-37 and induce ANCA antigen synthesis 
and could undoubtably play a role in all three syndromes [86]. The role 
of infection remains unclear for while there is broad agreement that 
infectious agents may trigger attacks, the concept that specific agents 
such as S. aureus or gram negative organisms generally are involved 
remains under question [45-48]. 
EGPA warrants a further comment. The favourable effect of therapy 
that decreases eosinophils suggests that this cell plays a pivotal role in 
the pathogenesis of EGPA. T cells appear to be vital and through Il-5 
eosinophils are under T cell control. This together with IgE production 
indicate that there is a TH2 response. Th1 and TH17 have been reported 
and could drive the granulomatous component of the diseases [87].
In conclusion, the nature of both genetic and environmental 
risk factors in the AASV is becoming clearer although by no means 
complete. Many can be entered into a plausible understanding of the 
disease pathogenesis, or at this stage in our understanding provide 
hypotheses that can be tested.
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